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SPECIFIC ANTIBODIES IN SCARLET FEVER.*t
KARL K. KOESSLER AND JESSIE M. KOESSLER.
(From the Memorial Institute for Infectious Diseases, Chicago.)
The demonstration of specific antibodies in scarlet fever has been
limited chiefly to those for streptococci. The numerous investi-
gations which deal with this subject, carried out with the object of
determining the role which the streptococcus plays in the etiology
of scarlet fever, may here be reviewed in brief, before we proceed
with the report of our own work.
ANTIBODIES FOR STREPTOCOCCI.
I. Agglutinins.-GrtinbaumI seems to have been the first to report on the agglu-
tination of streptococci of scarlet fever by the serums of scarlet-fever patients. He
simply states that he was able to isolate a coccus from a case of scarlet fever which
agglutinated with scarlet-fever serum.
Baginsky and Sommerfeld- examined the serums of scarlet-fever patients in the
third to the sixth week of the disease, for specific agglutinins of streptococci, which
were cultivated from cases of scarlet fever. Their results were absolutely negative.
At about the same time Moser and von Pirquets found that in 52 per cent of the
cases examined the serum caused marked agglutination of scarlatinal streptococci.
The serum from cases other than scarlet fever gave the reaction in a much smaller
percentage and only on higher dilution.
Salge and Hasenknopf4 made a comprehensive study of this question. They found
that emulsions of streptococci of scarlet fever were markedly agglutinated by the
serum of scarlatina in a dilution as high as I: 500, whereas the reaction failed with
streptococci from other sources, even with a lesser dilution of the serum. This specific
property of the serum vanishes toward the end of convalescence.
Dopters denies the specific relation of scarlet-fever serum toward homologous
streptococci. In his hands streptococci of various origin were agglutinated by the
serum of scarlet-fever patients and indeed in some cases the serum did not react with
streptococci from scarlet-fever cases. Dopter reaches the conclusion that the strep-
tococcus is not the specific agent of the disease.
Detot," and Detot and Boucart? arrived at similar results. Since the agglutina-
tion is not specific they reject its application as a diagnostic means and deny the role
of the streptococcus in the etiology of scarlet fever.
* Received for publication August 3I, I9II.
t This work was aided by a grant from the American Medical Association.
x Science Progress, I897, I, p. 6I6; Lancet, I897, I, p. 45I.
• Arch. f. Kinderh., I902, 33, p. r. 4 Jahrb. f. Kinderh., I903, 58, p. 2I8.
3 Centralbl. f. Bact. I, Orig., I904, 36, p. 692. 5 Compt. rend. Soc. de biol., I904, 56, p. 787.
6 Ibid., 57, p. 44.
7 Rev. mens. de malad. de l'enjance, I905, 23, p. 64.
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SPECIFIC ANTIBODIES IN SCARLET FEVER
In the same year there appeared an important article by Weaver' on the agglutina-
tion of streptococci by scarlet-fever serum. He too comes to the conclusion that the
agglutinins in the serum are not specific; that in the serum of patients with ery-
sipelas, pneumonia, and even other infections of non-streptogenous nature, agglu-
tinins for scarlet-fever streptococci may be present. Weaver points out further that
the discordant results of the different investigators may be due to the varying compo-
sition and reaction of the culture medium.
jogiches- found that the serum of scarlatina agglutinated streptococci of the most
different origin even in dilution of I: 500 and I: 600; the reaction appears in about
the fifth to the sixth week of the disease, but fails entirely in the beginning of the
disease. There exists no constant difference in the intensity of the reaction toward
the various strains of streptococci.
Rossiwal and Schicks found several streptococci, biologically different, in one case
of scarlet fever, which gave various high agglutination figures with Moser's antistrepto-
coccus serum.
Rudiger,' on the other hand, found that the serum of a sheep immunized against
a streptococcus isolated from the throat of scarlet-fever cases contained specific
agglutinins for this strain only, and that the Streptococcus viridans was not agglutinated.
II. Bacteriolysins -Weaver and Rudigers have shown that neither normal nor
scarlet-fever serum contains lysins for streptococci.
III. Phagocytosis and Opsonins.-The importance of phagocytosis in streptococcus
infections was demonstrated by Metchnikoff in the case of erysipelas. Denys and
Leclef6 showed that immune serum promotes the phagocytosis of streptococci, though
the term opsonin was not then used. The important contributions of Denys and
Marchand, Bordet, Hektoen, Neufeld and Rimpau, and RUdiger cannot be considered
here, as they deal mostly with the mechanism of experimental streptococcus infections,
while we limit ourselves here to the production of antibodies and their demonstration
in scarlet fever.
Ruth Tunnicliffr found that in the beginning of the disease the streptococco-
opsonic index is below normal in the majority of cases. As the acute symptoms sub-
side, the index rises above normal, to which it returns, at times, quite abruptly; and in
uncomplicated cases it usually remains normal during convalescence. Definite
localized streptococcus complications are inaugurated by a depression in the
streptococco-opsonic index, which rises again as improvement sets in. These vari-
ations of the opsonic index are limited to the streptococcus and are absent with
respect to pneumococcus, staphylococcus, and pseudodiphtheria bacillus; hence "the
streptococco-opsonin in scarlet fever is a specific opsonin."
Banks" arrives at similar results: In cases of scarlet fever running a normal
course the opsonic power is decreased during the early febrile period and rises to normal
or above normal with the defervescence. In fatal cases the opsonic power is markedly
subnormal. Complications alter the curve; the opsonic power is decreased at the
onset and during the earlier period of albuminuria, severe nephritis, and secondary
adenitis.. Banks believes in a definite relationship of the Streptococcus scarlatinae to the
disease, yet there is no striking difference in the results obtained with different varieties
I Jour. Infect. Dis., 1904, I, p. 9I.
a Centralbl, j. Bact., T, Orig., 1904, 36, p. 692.
3 Wien. klin. Wchnschr., 1905, 18, p, 3.
<Jour. Infect. Dis., 190 6, 3, p. 755·
5 Trans. Chic. Path. Soc., 1903, 5, p. 285.
6La cellule, 1895, II, p. 175.
7 Jour. Infect. Dis., 1907, 3, p. 304.
8 Jour. of Path. and Bact., 1907, 12, p. II3.
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368 KARL K. KOESSLER AND JESSIE M. KOESSLER
of streptococci. These findings of Tunnicliff and of Banks were confirmed later by
Jochmann and Michaelis.'
IV. Antitoxins.-All investigators, who have occupied themselves with the proof
of antitoxic substances in the serum of scarlatinal patients, have arrived at negative
results. Neither Besredka, nor Neufeld, nor Moser and Schwoner were able to demon-
strate antistreptocolysins (antihemotoxins) in the serum.
V. Bordet's Antibodies for Streptococci.-Besredka and Dopter- examined the
serum of scarlatinal patients for complement-deviating antibodies for streptococci.
Besredka himself previously had found with this method antibodies in streptococcus-
immune serums. As antigen they used streptococci cultivated from the throat and
blood of scarlet-fever patients. As they were not able to find a specific "fixateur" in
a single case they considered themselves justified in concluding that the streptococcus
plays no specific part in scarlet fever, but has the role of a secondary participant.
Foix and Malleins repeated these experiments with more positive results. They used
a polyvalent antigen of streptococci which had been cultivated from numerous cases
of scarlatinal angina. Though the cases examined are small in number the results
obtained are interesting. With twelve serums of scarlet-fever cases they obtained
deviation of the complement ten times. Controls made with serum of other strepto-
coccus infections, as erysipelas and puerperal sepsis showed complete hemolysis. The
antibodies were present as early as the fourth, and as late as the 38th, day.
Livierato- examined 18 scarlatinal serums using as antigen extracts of streptococci,
staphylococci, and pneumococci, typhus, colon, and influenza bacilli. Complete
inhibition of hemolysis was obtained by the streptococcus extract only, and this in
every case, though the streptococci used were not cultivated from cases of scarlet
fever. Livierato considers these findings an important contribution toward the proof
of the streptocogenous nature of scarlet fever.
H. E. Eggerss obtained "rather rough positive reactions in a certain proportion
of cases, but could not obtain the reaction in all cases." He points out the important
fact that broth cultures of streptococci used as antigen may be a source oferror in
performing the reaction, as sterile broth in itself possesses complement-fixing (anti-
hemolytic?) properties.
Schleissner" used suspensions of streptococci from scarlatina, erysipelas, puerperal
sepsis, and panophthalmia as antigen. The serum of scarlatina, especially from the
seventh to the 35th day, reacted positively with scarlatinal streptococci, whereas
control serums from other affections never gave a positive reaction. With erysipelas
streptococci, scarlet-fever serums never gave deviation, though some reacted positively
with the streptococci of puerperal sepsis and panophthalmia. This latter reaction,
however, was quantitatively weaker than the reaction with the scarlatinal strep-
tococci.
From all these investigations it results clearly that the serum ofscarlatina patients
contains antibodies for the streptococcus. This speaks undeniably for the biological
relation of this microorganism to scarlet fever. The existence of a specific scarlatinal
streptococcus, however, is not demonstrated by this work, and no light has been shed
on the primary etiology of the disease. The very presence of antibodies cannot solve
the problem whether the streptococcus is the primary agent of the disease or a secon-
I Berl. klin. Wchnschr., 1910,47, p. 921.
a Ann. de l'Inst. Pasteur, 1904, 18, p. 373.
sPresse med., 1907, 15, p. 777.
4 Centralbl. f. Bact., I, 54, p. 422.
5 Chic. Path. Soc., 1908, 7, p. 166 .
6 Folia serologica,1909,3, p. 271.
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dary invader. And even if it had been shown that these reactions were obtainable only
with scarlatinal serum, and streptococci cultivated from scarlatina, the question of
the etiology of the disease would still be unsolved. In this connection the work of
DeWael and Sugg- may be recalled. They found that the streptococci, constantly
present in smallpox, are specifically and exclusively agglutinated by the serum and other
serous liquids of variola patients and convalescents (dilution I: 400-1: 800), but not
by any other immune streptococcus serum. Yet one would hardly conclude from this
that the streptococcus is the etiologic agent of variola.
It therefore seemed appropriate to use those methods for the examination of
antibodies which have proved valuable in other diseases of unknown origin, and to
exclude as far as possible the streptococcus and its antibodies in the arrangement of
the experiment.
SPECIFIC ANTIBODIES IN SCARLET FEVER.
For the demonstration of antibodies in diseases, the germ of
which is unknown or incapable of cultivation, two methods may be
employed: one rests on the precipitating action, and the other on
the complement-binding function, of the anti-serum. Complement
deviation offers several advantages over precipitation; these are
chiefly:
I. Deviation of the complement occurs on the use of quantities
of antigen so small as not to show precipitation.
2. Complement-binding substances appear in the serum at a
time when precipitins cannot be demonstrated (Muir and Martin).
3. The complement-binding antibodies are more specific than
the precipitins (Bauer-Bruck).
It seemed therefore preferable to use the binding of the comple-
ment for the attempt at demonstration of specific antibodies in
scarlet fever. Such attempts are not new. In the last few years
numerous reports on complement fixation have appeared, instigated
by the report of Much and Eichelberg that they obtained fixation
of complement with scarlet serum and syphilitic antigen (positive
Wassermann reaction). Almost all the following investigations were
undertaken with the view only of testing the credibility and speci-
ficity of the Wassermann reaction, without consideration of the
question as to the presence of specific antibodies in scarlatina.
The fact that some scarlatinal serums give, with some syphilitic
extracts, complement deviation, though not impairing the prac-
tical value of the Wassermann reaction for syphilis, is of the
1 Arch. intern. de Pha!'m. et de /.herap., 1903, 12, p. 205.
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370 KARL K. KOESSLER AND JESSIE M. KOESSLER
greatest importance in respect to the use of Bordet's and Gengou's
phenomenon as a method of searching for antibodies for an un-
known etiologic agent in scarlet fever.
The explanation of a positive Wassermann reaction in some cases
of scarlet fever may lie in particular properties of the extract of
the serum, or in the interaction of both. Thus, for instance, it is
obvious that the presence of streptococci, or their soluble sub-
stances, in the antigen may give rise to complement deviation with
scarlatina serums. This holds for watery organ extracts as well
as for alcoholic ones. It was shown by Rudiger that suspensions
of organ extracts have no inhibitory effect on the multiplication of
streptococci. As far as alcoholic extracts are concerned, it may
be emphasized that our conceptions regarding the insolubility of
bacterial antigens in alcohol deserve complete revision. Thus,
for instance, Levaditi and Mutermilch' have recently proved that
those antigenetic constituents of cholera vibrios which are essential
for the deviation of complement are soluble in 85 per cent alcohol.
What is true for the cholera vibrios must be conceded may be the
case of other microorganisms. In the selection of a proper antigen
for the investigation of antibodies in scarlet fever this fact must be
borne in mind.
Concerning previous work with the aim of finding whether
specific antibodies are present in the serum.of scarlet-fever patients,
with the exception of antibodies for streptococci, the following
rnay be mentioned:
Handel and Schultz/ in the second part of their paper, report complement devia-
tion by the serum of scarlet-fever patients on the use of an extract of the liver of a child
who had died of a complication of scarlet fever (empyema). With a watery extract
they obtained complete complement fixation in 24 cases of 3I. The authors emphasize
that definite conclusions cannot be drawn from these results with regard to the com-
plement deviation in scarlet fever with homologous extracts. The chief difficulties
which arise in estimating the result of these investigators seem to be the following:
I. The antigen (watery extract of the liver) was obtained from a child who had
died of an empyema, thus of a secondary infection.
2. No facts as to the etiology of this empyema are given.
Since it possibly was a case of streptococcus infection, the extracts should have
been tested with serum of patients suffering from streptococci infection and with
streptococcus-immune serum. The positive findings might have been called forth by
streptococci or by the related germ causing the empyema.
r Compt. rend. Soc. de biol., 1908, 64, p. 406. 2 Ztschr. f. Immunitatsf., 1908, I, p. 9I. •
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SPECIFIC ANTIBODIES IN SCARLET FEVER
Uffenheimer- used as antigen the serum of children in the very first stages of the
disease and as antibody the serum of convalescents. These experiments proved entirely
negative; no inhibition of hemolysis occurred. Uffenheimer, probably rightly, con-
siders the fault of his experiments to lie in too slight concentration of the antigen.
Sommerfeld- also used as antigen a watery extract of the liver of scarlet-fever
victims. Of 40 serums, 18 reacted positively, 22 negatively. The paper contains
no reference regarding the testing of the extract with streptococcus-immune serums.
Hecht, Lateiner, and Wilenkoi examined 119 scarlet-fever serums for complement
fixation, using alcoholic extracts of liver of scarlet-fever patients, all with negative
results. They came to the conclusion that no specific properties are present in the
scarlet-fever liver.
These investigations, with the exception of Uffenheimer's, are
shaped directly after Wassermann's method. So far as the demon-
stration of Bordet antibodies is concerned, this could be regarded
only as an advantage. It is, however, different if we take into
consideration the hypothetical basis and the conditions for such
experiments. By far the most important of the preliminary
questions is the selection of an appropriate antigen.
ANTIGEN.
In the selection of an appropriate antigen it seemed to us a
conditio sine qua non to choose such organs as seemed to speak
clinically as well as anatomically for a place of predilection of the
virus. These conditions seem best fulfilled by the kidney, lymph
glands, and scales of the skin. We also used liver in order to control
the results of previous investigations.
The conditions which an appropriate antigen must fulfil for use
in the search for a specific scarlatinal virus seemed to us to be the
following:
1. The organs must come from an acute, toxic case of scarlet
fever in which the patient succumbed rapidly and without secon-
dary infections and complications.
2. The blood of the patient examined in the last days before
death should contain no streptococci.
3. The blood serum ought further, on being tested with an active
scarlatinal streptococci emulsion, to show no deviation of the com-
plement. The activity of the streptococcus antigen used should
be tested with the corresponding immune serum.
I Munch. med. Wchnschr., 19°9, 56, p. 2471. 2 Arch. j. Kinderh., 19°9, 50, p. 38.
3 Wien. klin. Wchnschr., 19°9, 22, p. 523; Ztschr.], Immunitiitsj., 19°9, 2, p. 356.
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372 KARL K. KOESSLER AND JESSIE M. KOESSLER
4. The watery organ extracts tested with antistreptococci-
immune serum should show no deviation of complement.
From the specially mild character of the scarlet fever in Chicago,
it was clear that it was not easy to find such foudroyant toxic cases
as answered to these four conditions. We succeeded after long
preliminary tests in finding three cases the conditions in which
corresponded to all the demands which we had placed on a suitable
antigen.
I. A. S.-Sick two days and removed to hospital on third. Three years old.
No previous diseases. Maximum temperature 104.6.c Great difficulty on swallow-
ing, slight swelling of the cervical lymph glands. Very marked, fiery-red exanthem,
relative bradycardia" and arrhythmia, delirium, slight albuminuria. Death on the
fifth day.
II. E. W.-Entered hospital on the second day of the disease. Boy, nine years
old. Only previous disease was measles. Maximal temperature 103.8, angina,
exanthem, symptoms of cerebral irritation, tachycardia. Death on the fourth day.
III. H. B.-Boy, six years old. Entered hospital on the fourth day of the
disease. Angina, exanthem, albuminuria, nephritis on the tenth day. Death occurred
on the 15th day with uremia.
The organs were removed from the bodies a few hours after
death. We used only watery extracts in our experiments, prepared
in the following way: The organs were cut up into small pieces with
scissors and then with the addition of physiologic salt solution
containing 25 per cent phenol rubbed up into a fine emulsion and
dried in the vacuum into a hard mass. This was rubbed up into a
fine powder and preserved in amounts of I gm. in sealed tubes.
For the experiment one-gram powder for every 30 c.c. of physio-
logic salt solution plus 0.25 per cent phenol was taken. The mixture
was shaken for two hours in the shaking apparatus and then placed
in a brown bottle in the icebox. After 48 hours the extract is
ready for use. The required amount is rendered clear by centrifu-
gation immediately before use.
The kidneys, lymph glands, and liver were treated in this way.
The scales were obtained from a large number of cases. In
order to macerate them completely, we allowed them to stand in a
IS per cent antiformin solution for 72 hours. The excess of alkali
was removed by the addition of 5 per cent sulfuric acid, drop-wise,
and of chlorine by a 5 per cent sodium-hyposulfite solution.
The streptococcus emulsion which was used as control was
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SPECIFIC ANTIBODIES IN SCARLET FEVER 373
prepared from blood-agar cultures of streptococci obtained by
blood culture from scarlet fever, and suspended in physiological
salt solution, the growth of one tube to about 2 c.c. salt solution.
Before use this emulsion was tested for its inhibiting and hemolytic
effect and that amount employed as a test of the serum of moribund
cases, which gave complete hemolysis with the system. For
instance:
Streptococcus Physiologic Amboceptor
I
Emulsion Salt Solution Complement (3X Hemolytic Blood ResultDose)
I.O C.c........ 1.0 c.c, · I in I c.c. I C.C. I c.c,
r
No hemolysis
·5 c.C........ I.5 c.c, · I in I c.c. I C.C. I C.C. Hemolysis
·4 c.c........ I.6 c.c, · I in I c.c, I C.C. I C.C.
·3 C.c........ I.7 C.C. · I in I C.C. I C.C. I c.c. Sli~ht helll;?lysis
• 2 c.c........ I.8 c.c. · I in I c.c. I C.C. I C.C.
. IS C.C........ 1.85 c.c, · I in I c.c. I C.C. I c.c . Complete ::
. I C.C........ I.9 c.c. · I in I c.c. I C.C. I C.C.
.05 C.C........ 1.95 c.c. · I in I c.c, I C.C. I C.C. " "
The extracts were used in amounts of IS per cent in testing the
scarlet-fever serum. Only the scarlatinal streptococcus emulsions
that gave complete inhibition with streptococcus-immune serums
were used.
ANTISERUMS.
The serums of scarlet-fever patients were obtained in all periods
of the disease, from the fourth day up to the I02d day. The blood
was collected sterile by puncture of the vein of the arm. After
coagulation was complete, the serum was pipetted off, centrifugated,
and when entirely clear, heated at 56° for 30 minutes. We em-
ployed only inactivated serum, which was obtained on the day of
the experiment.
COMPLEMENT.
Fresh guinea-pig serum was used as complement. It was
titrated exactly against the hemolytic system and twice the mul-
tiple of the dose of complement was used, which just caused com-
plete hemolysis.
HEMOLYSIN.
As amboceptor was used the serum of rabbits immunized against
sheep's blood. In order to know whether normal amboceptor
for sheep's blood was contained in the human serum, we tested
this every time without the addition of antigen and amboceptor
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(see Tube NO.4 in Example 2). If by this control test we obtained
hemolysis, we removed the natural sheep amboceptor by absorp-
tion and then repeated the experiment. The procedure employed
was as follows: 3 c.c. inactivated serum and I c.c. sheep's blood
corpuscles, washed three times, were allowed to remain in contact
for one-half hour in the icebox. Then they were centrifugated, and
the reaction was carried on with the serum, which was pipetted off.'
BLOOD.
The blood was a 5 per cent suspension of sheep corpuscles in
physiologic salt solution.
CONTROLS.
Each extract was tested: (r ) with antistreptococcus-immune
serum, (2) for hemolytic (hemotoxic) action, (3) for anticom-
plementary action, (4) with normal serum, and (5) with serums
of other diseases, such as measles, erysipelas, nephritis, etc.
The normal extracts which served as controls were tested in the
same way.
Each serum was tested: (r ) for anticomplementary action
(without antigen), (2) for hemolytic action without antigen and
without amboceptor, and (3) with normal extract.
After titration of the amboceptor and complement and examina-
tion of the organ extracts, the chief experiment was made in the
following way:
EXAMPLE OF EXPERIMENT.
"
"
"
"
Result
No hemolysis
Complete "
No "
Complete ::
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I·C.C.
I C.C.
I C.C.
Blood
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C •
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
I C.C.
Complement Amboceptor
• 2 scarlet
.. I "
.2 normal
. I
.:4'ly~ph'giand"""
.2" "
· 2 ''" "
..I" "
. 4 normal lymph gland
· 2" " "
· 2 " " "
:~:: :: ::
· I" " "
Extract 1__se_ru_m__
I I
•
I I
_
.2 lymph gland scarlet .2 scarlet
I. I" " " .I"
• • • • . • • • • • • • • • • • . • • • • • 2 "
.. 2 "
Tube
I ...
2 •..
3 .
4 ..
:; .
6 .
7 .•.
8 ...
9· ..
10 .
II .
12 •..
13 .
14 .
~& :::117 ...
I We have used this control for more than one year in our routine work with the Wassermann reaction
and can recommend it most warmly, since negative reactions with surely syphilitic serum can be avoided
in this way.
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TABLE I.
375
Case
I. . .
2 ..•..........•..
3··············· .
4··············· .
5· .
6 .
7 .. · · ..
8 < •.••••
9··············· .
10 .
II .
12 .
13· .
14· .
IS· .
16 , .
17· .
18 .
19· I
20 ".
21 ••...•.•••......
22 ••...•••.•...••.
23··············· .
24· .
25· .
26 .
27· .
28 .
29··············· .
30 .
3 1 .
3 2 ••••••.••••....•
33·······.······· .
H::::::::::::::::!
37· ···············1
38 i
39· .
4°··············· .
41 .
1~:::::::::::::::: j
44·······.······· '1"4S· .
46 .
47···.·.· ·.··· .
48 .
~~:::::::::::::::: I
Name of
Patient
M.B.
D.G.
H.B.
J.e.
N.L.
S.F.
s.L.
L.E.
W.G.
B.
L.M.
L.P.
e.G.
B.F.
D.A.
W.B.
W.L.
B.K.
S.E.
KO.
D.V.
D.R
G.R.
R.R
W.E.
B.M.
B.A.
S.M.
S.M.
A.H.
D.M.
J.R
e.B.
A.M.
L.e-
V.H.
B,J.
e.E.
W.B.
R.G.
B,].
K.M.
M.K.
B.M.
B.D.
L.W.
KE.
RR.
S.H.
e.M.
G.J.
Age in Years
10
8
7
9
10
1.5
8
S
16
7
8
12
12
2·5
16
3
3
24
5
5
5
10
15
5
49
3
4
6
6
7
8
7
3
22
18
3
5 ·5
16
17
4
r6
5
5
4
S
21
15
8
4
8
12
Day of Sick-
ness when
Blood Was
Examined
3
6
14
II
14
7
15
16
19
8
12
13
12
II
4
7
18
13
9
13
8
8
13
19
16
5
7
19
42
14
5
9
17
II
16
9
13
14
19
21
5
II
14
9
10
3
12
19
16
5
10
Kidney
Extract
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
Liver
Extract
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
In this way each scarlet serum was tested with the various organ
extracts.
Beside normal serum, serums of measles, diphtheria, erysipelas,
malignant tumors, tuberculosis, and nephritis were used as controls.
None of these control serums prevented hemolysis with the extract.
We first examined 50 cases with liver and kidney extracts. The
results are given in Table 1. Further, 25 cases with lymph glands,
kidney and liver extracts (Table 2). Since the extract of lymph
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TABLE 2.
I Dayo!Name of Sickness Lymph Kidney Liver
Case Patient Age when Blood Gland Extract ExtractWas Extract I
Examined I
5I .............. P.L. 20 II + - -52 .............. H.E. 7 15 + + +53···· .......... C.A. IS Q + - -
54··· ........... K.E. 3° 13 + + -55· ............. R.S. 8 12 + - -56 .............. S.R. 4·50 8 - - -
57· ............. L.C. 25 15 + + +58 .............. P.S. 7 9 - - -
59···· .......... K.A. 6 17 + + -60 .............. R.R.* I.661 19 + + +6I .............. G.M. 2·50 8 - - -
62 .............. B.B. 18 12 + + -63··· ........... H.L. 30 7 - - -
64··· ........... D.M. 28 II + + -65·.· ........... L.F. 12 15 + + +66 ..........".... L.M.B. 28 9 + - -
6," "I
J.A. 24 II + + +68 .............. B.S. 7 14 + + -
69··· ........... R.R. II 13 + + -70 .............. E.H. 23 15 - +
I
+7I .............. M.A. 24 14 + - -
"I
W.C.
•
8 19
I
- + +
73············· . S.L. 9 II + - -
74· ............. B.G. 6 15 - + -75· ............. W.V. 4 13 - -
* Had scarlet fever twice in one year.
+ Designates inhibition of hemolysis.
- Designates hemolysis.
glands proved the most effective, far more so than all the others, we
limited our further work to experiment with this extract alone
(Table 3).
The extract prepared of the scales proved negative in all in-
stances and therefore no reference is given to this work here.
If now the positive reactions recorded in the three tables are
compared, we see that:
Of 75 cases, 43 were positive with kidney extract, 57.3 per cent.
Of 75 " 25" " "liver 32"
Of II8 " 81" " "lymph-gland extract, 68.6 per cent.
Thus the extract prepared from the cervical lymph glands
proved the most powerful antigen.
An extract prepared from a normal kidney of a scarlet-fever
case and from one of a case of scarlet-fever nephritis showed no
difference in activity.
It is striking that of the serums examined of cases of nephritis
scarlet fever, all gave a positive reaction in each case.
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TABLE 3.
Day of
Name of Sickness LymphCase Patient Age When Blood GlandWas Extract II
Examined
-
7 6 .............. A.R. 7 II +
77 .............. D.V. 6 15 +
78 .............. F.R. 5 9 -
79·· ............ F.M. 7 12 +F.M. 7 58 +
8o .............. P.M. 16 17 +
81 .............. KA. 19 12 +KA. 19 3 1 +
82 ....•......... W.F. 9 4 -
83 .............. B.A. 8 17 +
84············· . T.N. 20 13 +
85 .. •······.··· . L.F. 9 16 +
86 .............. M.H. 12 29 +
87 .............. B.R. 22 14 +B.R. 22 46 +
88 .............. E.A. 9 12 -
89 .............. Z.J. 7 5 -
9°············· . M.K. 18 8 -
91 ... ........... M.M. 20 15 +M.M. 20 39 +
9 2 .............. S.T. 29 4 -
93·.·· .......... F.1. 22 15 +
94············· . N.D. 21 II +
95············· . H.R 21 15 +
96 .............. S.E. 28 14 +
97·· ............ K.A. 5 24 +KA. 5 63 +
98 .............. E.R. 15 21 +
99············· . T.C. 23 12 -
100 .............. M.G. 15 13 -
101 .............. G.W. 12 14 +
102 .............. 1.1. 6·5 17 +1.1. 6.5 84 +
103·· ............ W.E. 9 4 +
104 .............. 1.1. 6.5, 20 +
105··· ........... G.P. 4 15 +
106 .............. L.S. 9 13 +
107 .. ····· ....... C.A.* 27 12 -
108 .............. W.C. S 17 +W.C. 5 46 +
109············· . D.W. 2 14 -
110.............. A.R. 28 19 +A.R. 28 102 +
III .............. F.G. 16 28 +
112 .............. E.H. 18 21 +
113·· ............ S.G. 3 16 -
114· ............. G.A. 28 13 -
115· ............. B.M. 5 17 +
116 .............. P.E. 22 18 +P.E. 22 48 +
117· ............. L.S. 12 15 +
11-8.............. S.F. 5 12 -
119· ............. S.E. 7 12 +
120 ....•......... S.G. 4 4 -
121 .............. W.A. 12 15 +W.A. 12 35 +
122 .............. F.M. 6 13 +
123 .............. F.D. 7 14 +
124 .............. F.S. 7 14 +F.S. 7 45 +
125 .............. H.M. 12 19 -
126 .............. S.M. 22 12 -
127· ......•...... H.O. n: 10 +
128 ..-............ D.E. 7 15 +
* Designates nephritis.
+ Designates inhibition of hemolysis.
- Designates hemolysis.
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TABLE 3.-Continued.
i
Day of
Name of Sickness LymphCase Patient Age When Blood GlandWas Extract II
Examined
129 .............. M.H.
I
9 17 +13°· ............. W.M. 6 13 +13 1 .............. D.C. 19 II -
13 2 .............. F.H. 12 16 +133 .............. H.R. 6 13 -
134 .............. P.E. 6 IS +13S· ............. F.F. 8 18 +136 .............. S.M. 4·S 12 +
137 .............. J.E. 4 I I -
138 ........•..... M.A. 7 24 +M.A. 7 69 +
139· ............. M.J. 12 20 +140 .............. M.A. 10 21 +
14 1 .............. T.M. 8 II +14 2 .............. McC,J. 27 i 14 +
143····.········ . W.M. 26 IS -
144.............. L.E. 16 13 +
145 .............. L.J. I I 24 +
14 6 .............. S.F. 13 21 +
147 .. · ••...... ·· . T.L. 8 19 -
148 .............. O'B.J. 10 17 I +149.··· .......... L,J. 22 14 -
150 .............. L.L. 17 24 +lSI .............. C.M. 29 19 +
IS2 .......... , ... A.R. 4 16 -
153· ............. W.M. 23 27 +
154· .... "......... C.F. 5 23 +
ISS· ............. D.G. 17 21 +
IS6 .............. M.B. 8 18 +157· ............. W.S. 4 24 -
158 .............. W.F. 14 12 +
IS9· ............. H.R. 5 14 +160 .............. M.E. 22 17 -
161 .............. S.L. 12 2S +S.L. 12 38 +162 .............. B.L. 9 2I +163 .............. M.L. 3 18 -
164 .............. F.G. 13 17 -
165· .......•..... V.G.F. 17
I
19 +V.G.F. 17 34 +166 .............. V.G.W. 15 20 +
167 .............. L.F. II 17 +
.. Designates nephritis.
+ Designates inhibition of hemolysis.
- Designates hemolysis.
In respect to the time of first appearance of the antibodies,
it may be said that they do not seem to be present in the blood in
demonstrable quantities before the onset of the second week, the
eighth day being the earliest in which positive reaction was
obtained. So far as the duration of the action is concerned, the
serum was found to be active in the r ath week, and in one case
of scarlet nephritis even in the r6th week.
The activity of the extracts gradually diminishes; when in
March our work was interrupted, to be begun again in May, the
 at U
niversity of N
ebraska-Lincoln Libraries on June 7, 2016
http://jid.oxfordjournals.org/
D
ow
nloaded from
 
SPECIFIC ANTIBODIES IN SCARLET FEVER 379
lymph-gland extract formerly so active had lost its antigenetic
properties, and a new extract (II) had to be prepared.
The following conclusions would seem to be suggested by the
results obtained:
I. The serum of scarlet-fever patients contains specific anti-
bodies for an unknown virus.
2. This unknown virus seems to be present especially in the
cervical lymph glands.
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